Todd McAllister Blood vessels made through tissue engineering are being trialled in humans and may provide a future source of grafts from coronary applications. That is the latest from a California-ba
Todd McAllister
Blood vessels made through tissue engineering are being trialled in humans and may provide a future source of grafts from coronary applications. That is the latest from a California-based company, Cytograft, who presented details of their methods and current human trial at the AHA meeting. Todd McAllister told Audio Medica how it all works.
[audio:https://www.audiomedica.com/podcasting/aha2005/Todd_McAllister.mp3]